Both amyloid-beta and tau are believed to synergistically drive neurodegenerative processes involved in AD (Bloom, 2014; Lloret et al., 2015; Stancu, Vasconcelos, Terwel, & Dewachter, 2014). Here, MAPT is linked to Alzheimer disease.